Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

CARB-X Commits $48M for Antibiotic Resistance R&D

A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately. . . . → Read More: CARB-X Commits $48M for Antibiotic Resistance R&D

FDA Approves Multiple Sclerosis Therapy

The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease. . . . → Read More: FDA Approves Multiple Sclerosis Therapy

Climate-Resistant Oilseed Crop Plant Developed

An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate. . . . → Read More: Climate-Resistant Oilseed Crop Plant Developed

Univ. of California to Gain European Crispr-Cas9 Patent

A patent dispute among top research universities took another turn, as the European Patent Office announced its intention to grant a patent to University of California for its genome editing techniques. . . . → Read More: Univ. of California to Gain European Crispr-Cas9 Patent

T-Cell Therapy Trial Begins for Autoimmune Diseases

A biotechnology company began testing on humans an experimental drug to increase healthy T-cells in the immune system for people with autoimmune disorders. . . . → Read More: T-Cell Therapy Trial Begins for Autoimmune Diseases

Genetic Techniques Speed Brain, Muscle Cell Production

A new technology targets the expression of genes in stem cells to produce specific brain and muscle cells on demand and in a few days, a fraction of the time now required. . . . → Read More: Genetic Techniques Speed Brain, Muscle Cell Production

Regeneron to Sequence 500K UK Biobank Genomes

A biotech company and health database center are partnering with drug maker GlaxoSmithKline to produce genomic data on 500,000 individuals for drug discovery. . . . → Read More: Regeneron to Sequence 500K UK Biobank Genomes

Trial to Test Gene Therapy for Inherited Eye Disease

A spin-off enterprise from University of Oxford in the U.K. began enrolling participants in a clinical trial testing gene therapy to correct a genetic eye disease. . . . → Read More: Trial to Test Gene Therapy for Inherited Eye Disease

Organ Transplant Start-Up Gains $38M in Early Funds

A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round. . . . → Read More: Organ Transplant Start-Up Gains $38M in Early Funds

Allergan to Option Gene Editing for Eye Diseases

International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard. . . . → Read More: Allergan to Option Gene Editing for Eye Diseases